Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-01-31 4:55 pm Purchase | 13G | ITERUM THERAPEUTICS PLC SHS NE ITRM | Point72 Asset Management L.P. | 850,001 6.300% | 850,001 (New Position) | View |
| 2022-01-03 5:30 pm Sale | 13G | ITERUM THERAPEUTICS PLC SHS NE ITRM | SABBY MANAGEMENT LLC | 0 0.000% | -7,750,000 (Position Closed) | View |
| 2021-02-12 5:22 pm Purchase | 13D | ITERUM THERAPEUTICS PLC SHS NE ITRM | New Leaf Venture Management III L.L.C. | 5,331,800 4.500% | 3,864,256 (+263.31%) | View |
| 2021-02-12 5:01 pm Sale | 13D | ITERUM THERAPEUTICS PLC SHS NE ITRM | Sarissa Capital Management LP | 0 0.000% | -19,292,768 (Position Closed) | View |
| 2021-02-11 4:46 pm Sale | 13G | ITERUM THERAPEUTICS PLC SHS NE ITRM | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -13,730,376 (Position Closed) | View |
| 2021-02-10 3:40 pm Purchase | 13D | ITERUM THERAPEUTICS PLC SHS NE ITRM | Advent Life Sciences LLP | 2,890,085 3.500% | 2,010,683 (+228.64%) | View |
| 2021-02-10 2:27 pm Purchase | 13G | ITERUM THERAPEUTICS PLC SHS NE ITRM | SABBY MANAGEMENT LLC | 7,750,000 11.000% | 7,750,000 (New Position) | View |
| 2021-02-09 5:02 pm Sale | 13G | ITERUM THERAPEUTICS PLC SHS NE ITRM | Pivotal bioVenture Partners Fund I L.P. | 945,085 1.200% | -1 (-0.00%) | View |
| 2021-02-08 5:16 pm Purchase | 13G | ITERUM THERAPEUTICS PLC SHS NE ITRM | RA CAPITAL MANAGEMENT L.P. | 13,730,376 10.600% | 3,730,376 (+37.30%) | View |
| 2021-02-03 2:37 pm Unchanged | 13G | ITERUM THERAPEUTICS PLC SHS NE ITRM | CANAAN X L.P. | 1,733,170 4.000% | 0 (Unchanged) | View |
| 2021-01-29 06:32 am Sale | 13G | ITERUM THERAPEUTICS PLC SHS NE ITRM | INTRACOASTAL CAPITAL LLC | 2,577,774 4.990% | -117,032 (-4.34%) | View |
| 2020-12-02 4:31 pm Purchase | 13G | ITERUM THERAPEUTICS PLC SHS NE ITRM | RA CAPITAL MANAGEMENT L.P. | 10,000,000 18.900% | 10,000,000 (New Position) | View |
| 2020-11-23 5:02 pm Purchase | 13D | ITERUM THERAPEUTICS PLC SHS NE ITRM | Sarissa Capital Management LP | 19,292,768 30.950% | 19,292,768 (New Position) | View |
| 2020-11-10 09:02 am Unchanged | 13G | ITERUM THERAPEUTICS PLC SHS NE ITRM | WELLINGTON MANAGEMENT GROUP LLP | 0 0.000% | 0 (Unchanged) | View |
| 2020-11-02 06:26 am Purchase | 13G | ITERUM THERAPEUTICS PLC SHS NE ITRM | INTRACOASTAL CAPITAL LLC | 2,694,806 6.800% | 2,694,806 (New Position) | View |
| 2020-10-29 1:00 pm Unchanged | 13D | ITERUM THERAPEUTICS PLC SHS NE ITRM | Frazier Healthcare VII L.P. | 1,557,158 4.200% | 0 (Unchanged) | View |
| 2020-07-10 4:19 pm Purchase | 13G | ITERUM THERAPEUTICS PLC SHS NE ITRM | ARMISTICE CAPITAL LLC | 1,114,145 4.990% | 223,000 (+25.02%) | View |
| 2020-07-06 2:36 pm Purchase | 13D | ITERUM THERAPEUTICS PLC SHS NE ITRM | Frazier Healthcare VII L.P. | 1,557,158 7.300% | 18,842 (+1.22%) | View |
| 2020-06-16 11:48 am Unchanged | 13D | ITERUM THERAPEUTICS PLC SHS NE ITRM | Frazier Healthcare VII L.P. | 1,538,316 8.600% | 0 (Unchanged) | View |
| 2020-06-12 4:17 pm Purchase | 13G | ITERUM THERAPEUTICS PLC SHS NE ITRM | ARMISTICE CAPITAL LLC | 891,145 4.800% | 891,145 (New Position) | View |